Concepedia

Saralyn Lindsey

SL

19

Publications

2.3K

Citations

19

H-Index

1984

Active since

Affiliations

Pfizer (United States)(Current)

Brandeis University

Oregon Health & Science University

Saralyn Lindsey is an author at Pfizer (United States) specializing in medicine, vascular biology, and atherosclerosis.

Top concepts

Publications per year

1984–2002

19

Publications

19

Monocyte Chemoattractant Protein-1 Accelerates Atherosclerosis in Apolipoprotein E-Deficient Mice

Robert J. Aiello, Patricia-Ann K. Bourassa, Saralyn Lindsey et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1999 · 461 citations · Full text

, , +18

Increased Atherosclerosis in Hyperlipidemic Mice With Inactivation of ABCA1 in Macrophages

Robert J. Aiello, Dominique Brees, Patricia-Ann K. Bourassa et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2002 · 387 citations · Full text

, , +18

Leukotriene B4 Receptor Antagonism Reduces Monocytic Foam Cells in Mice

Robert J. Aiello, Patricia-Ann Bourassa, Saralyn Lindsey et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2002 · 248 citations · Full text

, , +18

Dietary saturated fatty acids (12:0, 14:0, 16:0) differ in their impact on plasma cholesterol and lipoproteins in nonhuman primates

K. C. Hayes, Andrzej Prończuk, Saralyn Lindsey et al. · American Journal of Clinical Nutrition · 1991 · 220 citations

, , +10

Will dietary ω-3 fatty acids change the composition of human milk?

WS Harris, W E Connor, Saralyn Lindsey · American Journal of Clinical Nutrition · 1984 · 184 citations

, , +8

Rows per page

1–5 of 19